NASDAQ:PLRX

Pliant Therapeutics Stock News

Healthcare > Biotechnology

Buy PLRX

*Your capital is at risk

$1.18

+0.0200 (+1.72%)

At Close: Jun 03, 2026

Pliant Therapeutics Announces Next Steps Following DSMB Recommendation on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis

08:00am, Thursday, 13'th Feb 2025

SOUTH SAN FRANCISCO, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that, per the charter of the trial's independent Data Safety Monitoring Board (D

Shareholder Rights Advocates at Levi & Korsinsky Investigate Pliant Therapeutics, Inc. (PLRX) Regarding Possible Securities Fraud Violations

05:15pm, Wednesday, 12'th Feb 2025

NEW YORK, NY / ACCESS Newswire / February 12, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Pliant Therapeutics, Inc. ("Pliant Therapeutics, Inc.") (NASDAQ:PLRX)

Pliant Therapeutics, Inc. Company Investigated by the Portnoy Law Firm

04:52pm, Wednesday, 12'th Feb 2025

Investors can contact the law firm at no cost to learn more about recovering their losses

Lost Money on Pliant Therapeutics, Inc. (PLRX)? Contact Levi & Korsinsky Regarding an Ongoing Investigation

11:15am, Tuesday, 11'th Feb 2025

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Pliant Therapeutics, Inc. ("Pliant Therapeutics, Inc.") (NASDAQ:PLRX)

PLRX ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Pliant Therapeutics, Inc. Investment

09:15am, Tuesday, 11'th Feb 2025

Levi & Korsinsky Announces an Investigation on Behalf of Pliant Therapeutics, Inc. (PLRX) Shareholders Who May Have Been Affected by Fraud

07:15am, Tuesday, 11'th Feb 2025

Pliant Therapeutics, Inc. (PLRX) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights

05:00am, Tuesday, 11'th Feb 2025

PLRX STOCK ALERT: Levi & Korsinsky Notifies Pliant Therapeutics, Inc. Investors of an Ongoing Investigation

03:00am, Tuesday, 11'th Feb 2025

Pliant Therapeutics, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - PLRX

12:59am, Tuesday, 11'th Feb 2025

Shareholder Rights Advocates at Levi & Korsinsky Investigate Pliant Therapeutics, Inc. (PLRX) Regarding Possible Securities Fraud Violations

11:00pm, Monday, 10'th Feb 2025

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Pliant Therapeutics, Inc. ("Pliant Therapeutics, Inc.") (NASDAQ:PLRX)

Pliant Therapeutics, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - PLRX

09:00pm, Monday, 10'th Feb 2025

Investors who Lost Money on Pliant Therapeutics, Inc. Should Contact Levi & Korsinsky about an Ongoing Investigation - PLRX

07:00pm, Monday, 10'th Feb 2025

Shareholder Rights Advocates at Levi & Korsinsky Investigate Pliant Therapeutics, Inc. (PLRX) Regarding Possible Securities Fraud Violations

05:00pm, Monday, 10'th Feb 2025

Pliant Therapeutics Pauses Lead Product Mid-Stage Trial In Patients With Stiff Lung Tissues

08:32am, Monday, 10'th Feb 2025

Pliant Therapeutics, Inc. PLRX stock is trading lower on Monday.

Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis

04:58pm, Friday, 07'th Feb 2025

Following DSMB recommendation, the Company has voluntarily paused enrollment and dosing in the BEACON-IPF Phase 2b trial and will monitor current patients while data is reviewed

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by